Bolt Biotherapeutics's total assets for Q3 2024 were $109.33M, a decrease of -11.95% from the previous quarter. BOLT total liabilities were $37.30M for the fiscal quarter, a -2.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.